Related Resources For many, a diabetes diagnosis can come as a life-changing surprise, but the journey leading
Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses the use of white blood cell colony stimulating factors (CSFs), including the drug products Fulphila, Fylnetra, Granix, Leukine, Neulasta, Neupogen, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, Udenyca, Zarxio, and Ziextenzo
Monitor factors that might affect absorption: oral pH, hydration level, time of day, position of drops under tongue
Ensure you are prioritising protein intake and, if possible, engaging in some form of resistance exercise (like lifting light weights or using resistance bands) to protect your lean tissue
Meaningful weight loss typically occurs gradually, and the most significant results often take time to develop